Updated OGE Senior Executive Service Performance Review Board, 43541-43542 [2017-19835]

Download as PDF Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices language interpretation or other reasonable accommodations, should contact Dayna C. Brown, Secretary and Clerk, at (202) 694–1040, at least 72 hours prior to the meeting date. PERSON TO CONTACT FOR INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. Dayna C. Brown, Secretary and Clerk of the Commission. [FR Doc. 2017–19955 Filed 9–14–17; 4:15 pm] BILLING CODE 6715–01–P FEDERAL MARITIME COMMISSION Sunshine Act Meeting Federal Maritime Commission. TIME AND DATE: September 20, 2017; 10:00 a.m. PLACE: 800 N. Capitol Street NW., First Floor Hearing Room, Washington, DC. STATUS: The first portion of the meeting will be held in Open Session; the second portion in Closed Session. AGENCY HOLDING THE MEETING: Matters To Be Considered: Portions Open to the Public 1. Briefing by Commissioner Dye on the Supply Chain Innovation Teams and Update from Global Liner Shipping Asia Conference 2. Staff Briefing on Review Process for Carrier and Marine Terminal Operator Agreements Portions Closed to the Public 1. Staff Update on Petition of the Coalition for Fair Port Practices (P4–16) CONTACT PERSON FOR MORE INFORMATION: Rachel E. Dickon, Assistant Secretary (202) 523 5725. Rachel E. Dickon, Assistant Secretary. other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than October 2, 2017. A. Federal Reserve Bank of Cleveland (Nadine Wallman, Vice President) 1455 East Sixth Street, Cleveland, Ohio 44101–2566. Comments can also be sent electronically to Comments.applications@clev.frb.org: 1. SSB Bancorp, Inc., Pittsburgh, Pennsylvania; to engage de novo in extending credit and servicing loans pursuant to section 225.28(b)(1) of Regulation Y. B. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. First Internet Bancorp, Fishers, Indiana; to acquire 9.99 percent of the voting shares of Lendeavor, Inc., San Francisco, California, and thereby engage in extending credit and servicing loans pursuant to section 225.28(b)(1) of Regulation Y. 2. Iowa State Financial Services Corporation, Fairfield, Iowa; to continue engaging in extending credit and servicing loans pursuant to section 225.25(b)(1) of Regulation Y. Board of Governors of the Federal Reserve System, September 12, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–19847 Filed 9–14–17; 11:15 am] BILLING CODE 6731–AA–P [FR Doc. 2017–19681 Filed 9–15–17; 8:45 am] FEDERAL RESERVE SYSTEM BILLING CODE 6210–01–P sradovich on DSKBBY8HB2PROD with NOTICES Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities FEDERAL RESERVE SYSTEM The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or VerDate Sep<11>2014 16:54 Sep 15, 2017 Jkt 241001 Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 43541 that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than September 27, 2017. A. Federal Reserve Bank of Atlanta (Chapelle Davis, Assistant Vice President) 1000 Peachtree Street NE., Atlanta, Georgia 30309. Comments can also be sent electronically to Applications.Comments@atl.frb.org: 1. Kenneth Ray Lehman, Arlington, Virginia; to acquire voting shares of ABB Financial Group, Inc., and thereby indirectly acquire shares of Affinity Bank, both of Atlanta, Georgia. Board of Governors of the Federal Reserve System, September 12, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–19680 Filed 9–15–17; 8:45 am] BILLING CODE 6210–01–P OFFICE OF GOVERNMENT ETHICS Updated OGE Senior Executive Service Performance Review Board AGENCY: Office of Government Ethics (OGE). ACTION: Notice. Notice is hereby given of the appointment of members of the updated OGE Senior Executive Service (SES) Performance Review Board. DATES: September 18, 2017. FOR FURTHER INFORMATION CONTACT: Shelley K. Finlayson, Chief of Staff and Program Counsel, Office of Government Ethics, Suite 500, 1201 New York Avenue NW., Washington, DC 20005– 3917; Telephone: 202–482–9300; TYY: 800–877–8339; FAX: 202–482–9237. SUPPLEMENTARY INFORMATION: 5 U.S.C. 4314(c) requires each agency to establish, in accordance with regulations prescribed by the Office of Personnel Management at 5 CFR part 430, subpart C and § 430.310 thereof in particular, one or more Senior Executive Service performance review boards. As a small executive branch agency, OGE has just one board. In order to ensure an adequate level of staffing and to avoid a constant series of recusals, the designated members of OGE’s SES Performance Review Board are being SUMMARY: E:\FR\FM\18SEN1.SGM 18SEN1 43542 Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices drawn, as in the past, in large measure from the ranks of other executive branch agencies. The board shall review and evaluate the initial appraisal of each OGE senior executive’s performance by his or her supervisor, along with any recommendations in each instance to the appointing authority relative to the performance of the senior executive. This notice updates the membership of OGE’s SES Performance Review Board as it was most recently published at 78 FR 76148 (December 16, 2013). Approved: September 13, 2017. David J. Apol, Acting Director, U.S. Office of Government Ethics. The following officials have been appointed members of the SES Performance Review Board of the Office of Government Ethics: Shelley K. Finlayson, [Chair], Chief of Staff and Program Counsel, Office of Government Ethics; Stuart Bender, Director, Office of Ethics, U.S. Department of Agriculture; Judith S. Kaleta, Deputy General Counsel, U.S. Department of Transportation; and Shira Pavis Minton, Ethics Counsel, Office of the Ethics Counsel, Securities and Exchange Commission. [FR Doc. 2017–19835 Filed 9–15–17; 8:45 am] BILLING CODE 6345–03–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–17–0888] sradovich on DSKBBY8HB2PROD with NOTICES Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of VerDate Sep<11>2014 16:54 Sep 15, 2017 Jkt 241001 information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Within 30 days of this notice, direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Proposed Project Factors Influencing the Transmission of Influenza (OMB Control Number 0920–0888; Expired 6–30–2017)— Reinstatement with change—National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Institute for Occupational Safety and Health (NIOSH) is authorized to conduct research to advance the health and safety of workers under Section 20(a)(1) of the 1970 Occupational Safety and Health Act. Influenza continues to be a major public health concern because of the substantial health burden from seasonal influenza and the potential for a severe pandemic. Although influenza is known to be transmitted by infectious secretions, these secretions can be transferred from person to person in many different ways, and the relative importance of the different pathways is not known. The likelihood of the transmission of influenza virus by small infectious airborne particles produced during coughing and breathing is particularly unclear. The question of airborne transmission is especially important in healthcare facilities, where influenza patients tend to congregate during influenza season, because it directly impacts the infection control and personal protective measures that should be taken by healthcare workers. Work under the previous approval showed that patients infected with influenza virus produce airborne particles containing viable airborne influenza virus during both breathing PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 and coughing, but that breathing may generate more airborne infectious material than coughing over time. However, this work was hampered because the amounts of influenza virus in almost all of the aerosol samples were below the limit of quantification. Thus, CDC made the following changes to the project: (1) CDC will modify the cough and exhalation-aerosol collection system to collect aerosol particles continuously for 40 minutes, rather than collecting particles from discrete coughs and exhalations as in the previous study. This will increase the amount of influenza virus that is collected. (2) Researchers will collect a blood sample from each participant to allow testing for blood markers of influenza infection and a comparison of the levels of these markers to the amount of expelled influenza in aerosol particles. (3) Researchers increased the time required for participation from 63 minutes to 95 minutes to allow for a longer aerosol collection period and for the blood collection. (4) Researchers will recruit and test an equal number of control subjects without symptoms of respiratory illness in addition to subjects with influenzalike illness. This will allow the determination of the differences in blood biomarker levels between healthy and infected subjects. (5) Because of the longer participation time and because blood collection has been found to be a strong disincentive for participation, the token of appreciation for participating in the study has been increased from $25 to $40. The purpose of the proposed study is to gain a better understanding of the production of infectious aerosols by patients with influenza, and to compare this to the levels of biomarkers of influenza infection in the blood of these patients. To do this, researchers will collect airborne particles produced by volunteer subjects with influenza to test for influenza virus. Researchers will also measure the levels of influenza infection-associated biomarkers in blood samples from these subjects. A test coordinator will recruit volunteer adult participants by using a poster and flyers describing the study. Researchers will verbally screen interested potential participants to verify that they have influenza-like symptoms and that they do not have any medical conditions that would preclude their participation. Researchers will also recruit a matching number of healthy control participants. Researchers will ask qualified participants who agree to participate in E:\FR\FM\18SEN1.SGM 18SEN1

Agencies

Office of Government Ethics

[Federal Register Volume 82, Number 179 (Monday, September 18, 2017)]
[Notices]
[Pages 43541-43542]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19835]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF GOVERNMENT ETHICS


Updated OGE Senior Executive Service Performance Review Board

AGENCY: Office of Government Ethics (OGE).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given of the appointment of members of the 
updated OGE Senior Executive Service (SES) Performance Review Board.

DATES: September 18, 2017.

FOR FURTHER INFORMATION CONTACT: Shelley K. Finlayson, Chief of Staff 
and Program Counsel, Office of Government Ethics, Suite 500, 1201 New 
York Avenue NW., Washington, DC 20005-3917; Telephone: 202-482-9300; 
TYY: 800-877-8339; FAX: 202-482-9237.

SUPPLEMENTARY INFORMATION: 5 U.S.C. 4314(c) requires each agency to 
establish, in accordance with regulations prescribed by the Office of 
Personnel Management at 5 CFR part 430, subpart C and Sec.  430.310 
thereof in particular, one or more Senior Executive Service performance 
review boards. As a small executive branch agency, OGE has just one 
board. In order to ensure an adequate level of staffing and to avoid a 
constant series of recusals, the designated members of OGE's SES 
Performance Review Board are being

[[Page 43542]]

drawn, as in the past, in large measure from the ranks of other 
executive branch agencies. The board shall review and evaluate the 
initial appraisal of each OGE senior executive's performance by his or 
her supervisor, along with any recommendations in each instance to the 
appointing authority relative to the performance of the senior 
executive. This notice updates the membership of OGE's SES Performance 
Review Board as it was most recently published at 78 FR 76148 (December 
16, 2013).

    Approved: September 13, 2017.
David J. Apol,
Acting Director, U.S. Office of Government Ethics.

    The following officials have been appointed members of the SES 
Performance Review Board of the Office of Government Ethics: Shelley K. 
Finlayson, [Chair], Chief of Staff and Program Counsel, Office of 
Government Ethics; Stuart Bender, Director, Office of Ethics, U.S. 
Department of Agriculture; Judith S. Kaleta, Deputy General Counsel, 
U.S. Department of Transportation; and Shira Pavis Minton, Ethics 
Counsel, Office of the Ethics Counsel, Securities and Exchange 
Commission.

[FR Doc. 2017-19835 Filed 9-15-17; 8:45 am]
 BILLING CODE 6345-03-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.